RCEL
Avita Therapeutics Inc
Halal Rating :
Last Price
$8.67
Last updated:
Market Cap
-
7D Change
-1.7%
1 Year Change
-42.73%
Company Overview
Industries
Exchange
Next Earnings Date
AVITA Medical is a regenerative medicine company focused on developing and commercializing innovative therapies that harness the healing properties of a patient's own skin. Their flagship product, the RECELL System, is a device that enables healthcare providers to produce a suspension of Spray-On Skin Cells using a small sample of the patient's own skin. This technology is primarily used for treating acute thermal burns and other skin defects.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $19.55m | $34.71m | - | $1.36m | 0.00% | 3.92% |
| June 30, 2024 | $15.2m | $32.17m | - | $1.35m | 0.00% | 4.19% |
| March 31, 2024 | $11.1m | $29.67m | - | $1.36m | 0.00% | 4.57% |
Company Impact
Help us evaluate Avita Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.